SFJ Pharmaceuticals provides funding, expertise, and resources for clinical development and registration of pharmaceutical products.
SFJ Pharmaceuticals supports the clinical development and registration of pharmaceutical products through funding, expertise, resources, and global reach. Founded in 2009 by Robert DeBenedetto, who served as President and CEO, the company is based in Pleasanton, US. It raised USD 45 million in Series A financing in March 2009, co-led by Abingworth Management and Clarus Ventures, and USD 30 million in October 2013, led by Clarus Ventures. Blackstone also backed the company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in